IRIS
ETTARI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.537
NA - Nord America 2.380
AS - Asia 514
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
OC - Oceania 1
Totale 5.454
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.376
IE - Irlanda 810
SE - Svezia 585
IT - Italia 524
CN - Cina 322
SG - Singapore 128
DE - Germania 100
PL - Polonia 94
FI - Finlandia 90
UA - Ucraina 89
AT - Austria 67
GB - Regno Unito 65
FR - Francia 48
IN - India 47
BE - Belgio 27
RU - Federazione Russa 14
VN - Vietnam 10
NL - Olanda 8
CZ - Repubblica Ceca 7
NG - Nigeria 4
SC - Seychelles 4
CH - Svizzera 3
DZ - Algeria 3
EU - Europa 3
LV - Lettonia 3
ZA - Sudafrica 3
CA - Canada 2
KR - Corea 2
MX - Messico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
EG - Egitto 1
GR - Grecia 1
JP - Giappone 1
MA - Marocco 1
MD - Moldavia 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
TR - Turchia 1
Totale 5.454
Salva come PNG Salva come JPEG
Città #
Dublin 810
Chandler 551
Nyköping 438
Jacksonville 229
Messina 224
Beijing 179
Ashburn 172
Princeton 128
Medford 115
Warsaw 94
Des Moines 91
Dearborn 90
Cambridge 82
Singapore 80
Ann Arbor 71
Vienna 67
Boardman 39
Lancaster 33
Jinan 30
San Mateo 30
Brussels 23
Hyderabad 22
Wilmington 18
Pune 15
Rome 15
Shenyang 14
Augusta 13
Woodbridge 13
Aversa 12
Los Angeles 12
Montpellier 12
Taizhou 11
Dong Ket 10
Haikou 10
Nanjing 10
Zhengzhou 10
Hebei 9
Bari 8
Catania 8
New York 8
Brno 7
Francofonte 7
Helsinki 7
Houston 7
Santa Clara 7
Siderno 7
Berlin 6
Borghetto Santo Spirito 6
Caltagirone 6
Francavilla di Sicilia 6
Nanchang 6
Seattle 6
Tianjin 6
Milan 5
New Delhi 5
Ningbo 5
Norwalk 5
Riposto 5
Riva 5
Southampton 5
Fuzhou 4
Hangzhou 4
Jiaxing 4
Trecastagni 4
Amsterdam 3
Cape Town 3
Fontaniva 3
Lentini 3
Leonforte 3
Munich 3
Nocera Terinese 3
Patti 3
Piazza Armerina 3
Rosarno 3
Washington 3
Avola 2
Brussel 2
Cedar Knolls 2
Clearwater 2
Dongguan 2
Elk Grove Village 2
Enna 2
Falls Church 2
Ferrara 2
Fremont 2
Groningen 2
Guangzhou 2
Hefei 2
Katsina 2
Kemerovo 2
Kunming 2
Lagos 2
Lanzhou 2
Lappeenranta 2
Mazzarino 2
Milazzo 2
Modica 2
Napoli 2
Orsay 2
Palermo 2
Totale 4.024
Salva come PNG Salva come JPEG
Nome #
BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQ-induced psoriasis 108
Exploiting Curcumin Synergy With Natural Products Using Quantitative Analysis of Dose–Effect Relationships in an Experimental In Vitro Model of Osteoarthritis 101
Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma cells 87
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 86
Role of the microbiota in hematologic malignancies. 85
Design, synthesis and biological evaluation of novel rhodesain inhibitors for the treatment of Human African Trypanosomiasis 82
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 80
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 75
Constrained peptidomimetics as antiplasmodial falcipain-2 inhibitors 74
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 73
Development of novel irreversible rhodesain inhibitors as antitrypanosomal agents. 72
DEVELOPMENT OF NOVEL PEPTIDOMIMETIC ANALOGUES OF A HIGHLY POTENT AND SELECTIVE FALCIPAIN-2 INHIBITOR CONTANING A VINYL ESTER MOIETY 70
Design, synthesis and molecular modeling studies on peptidomimetic vinyl esters as falcipan-2 inhibitors 70
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors 69
Novel peptidomimetics containing different α,β-unsaturated electrophilic functions, as falcipain-2 inhibitors 69
Identification of noncovalent proteasome inhibitors with high selectivity for chymotrypsin-like activity by a multistep structure-based virtual screening 69
Cross-Metathesis Reactions in the Synthesis of Constrained Dipeptide Mimics as Potent Falcipain-2 Inhibitors. 68
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 68
G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives 68
Development of Novel Peptidomimetics Containing a VinylSulfone Moiety as Proteasome Inhibitors 68
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 67
Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma. 65
Design, synthesis and biological evaluation of peptidomimetics boronic acids targeting 20S proteasome 63
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 63
Design and synthesis of novel isoxazole-based HDAC inhibitors 62
Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors 61
A novel 2,3-benzodiazepine-4-one derivative AMPA antagonist inhibits G2/M transition and induces apoptosis in human leukemia Jurkat T cell line 61
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 59
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 59
Chloro-substituted Hoveyda-Grubbs ruthenium carbene: investigation of electronic effects 57
DEVELOPMENT OF NOVEL PEPTIDOMIMETICS CONTAINIG A VINYL SULFONE MOIETY AS PROTEASOME INHIBITORS 57
Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists 57
Development of pyridin-2-one derivatives as non-covalent inhibitors of immunoproteasome 57
Development of novel benzodiazepine-based peptidomimetics as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 57
Development of nonpeptidic vinyl and allyl phosphonates as active-site-directed inhibitors of falcipain-2 56
Falcipain-2 inhibitors 56
Mechanism of Inhibition of the GluA2 AMPA Receptor Channel Opening: The Role of 4-Methyl versus 4-Carbonyl Group on the Diazepine Ring of 2,3-Benzodiazepine Derivatives 56
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 55
Design and NMR conformational analysis in solution of β5i-selective inhibitors of immunoproteasome 54
Evaluation of curcumin irreversibility 54
Chloro-substituted Hoveyda-Grubbs ruthenium carbene: Investigation of electronic effects 53
Development of Peptidomimetics with a Vinyl Sulfone Warhead as Irreversible Falcipain-2 Inhibitors 53
Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors 53
Synthesis of novel peptidomimetics as inhibitors of protozoan cysteine proteases falcipain-2 and rhodesain 53
Discovery of novel peptidomimetics containing a benzodiazepine scaffold as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 53
Development of novel peptide-based Michael acceptors as antitrypanosomal agents 53
Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents 52
Development of novel amides as non covalent inhibitors of immunoproteasome 51
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 51
Formation of 3-Aminofuran-2-(5H)-ones and 3-Amino-1H-pyrrole-2,5-diones by Rearrangement of Isoxazolidines 50
Synthesis and anti-HIV activity evaluation of new phenyl ethyl thiourea (PET) derivatives 49
A novel benzodiazepine derivative that suppresses microtubule dynamics and impairs mitotic progression 49
Glutamate Binding-Site Ligands of NMDA Receptors 48
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain 47
Reazioni di cross metathesis: applicazione alla sintesi di peptidomimetici potenziali inibitori di falcipaina-2 47
Development of novel Michael acceptors targeting rhodesain as antitrypanosomal agents 47
Novel peptidomimetics as antiplasmodial falcipain-2 inhibitors 46
Novel 2H-Isoquinolin-3-ones Falcipain-2 Inhibitors as Antimalarial Agents 45
Development of peptidomimetic boronates as proteasome inhibitors 45
Synthesis of Peptidomimetics with the Benzodiazepine Nucleus as beta-turn mimic 45
Development of peptidyl Michael acceptors for S3 pocket investigation of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense 45
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 45
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 44
Effect of mammalian SERCA inhibitors on Plasmodium falciparum growth in vitro 43
Recent Advances in Nanotherapeutics for Multiple Myeloma 43
Novel peptidomimetic cysteine protease inhibitors as antimalarial agents 42
Mechanism and Site of Inhibition of AMPA Receptors: Substitution of One and Two Methyl groups at the 4-Aminophenyl Ring of 2,3-Benzodiazepine and Implications in the “E” Site 42
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei hodesiense 42
Development of Novel Selective Peptidomimetics Containing a Boronic Acid Moiety, Targeting the 20S Proteasome as Anticancer Agents 41
null 41
Formaldehyde exposure and acute myeloid leukemia: A review of the literature 41
Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis 41
Novel Peptidomimetics Containing a Vinyl Ester Moiety as Highly Potent and Selective Falcipain-2 Inhibitors 40
DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF PEPTIDOMIMETIC FALCIPAIN-2 INHIBITORS AS ANTIMALARIAL AGENTS 40
NMR conformational analysis in solution of a potent class of cysteine proteases inhibitors 40
Development of novel peptide-based Michael acceptors targeting rhodesain for the treatment of human african trypanosomiasis 40
Synthesis and Molecular Modeling Studies of Derivatives of a Highly Potent Peptidomimetic Vinyl Ester as Falcipain-2 Inhibitors 39
Development of peptidomimetic boronates as proteasome inhibitors 38
Composti antitumorali 38
Novel peptidomimetics containing a β-turn mimetic 1,4-Benzodiazepine scaffold as falcipain-2 inhibitors 37
Synthesis of constrained dipeptide mimics containing the benzodiazepine scaffold 36
Nonpeptidic Vinyl and Allyl Phosphonates as Falcipain-2 Inhibitors 36
Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors 36
Synthesis and pharmacological evaluation of α4β2 nicotinic ligands with a 3-fluoropyrrolidine nucleus 36
Discovery of novel reversible proteasome inhibitors by a multistep docking based virtual screening (VS) 36
Identification of a new series of non-covalent proteasome inhibitors with selectivity for β5-subunits 35
Development of novel pseudopeptides targeting the 20S proteasome as anticancer agents 35
Immunoproteasome and Non-Covalent Inhibition: Exploration by Advanced Molecular Dynamics and Docking Methods 34
Synthesis and biological evaluation of new 2-amino-6-(trifluoromethoxy)benzoxazole derivatives, analogues of riluzole. 34
Exploring the non-covalent ligand-binding mechanism on immunoproteasome by enhanced Molecular Dynamics 34
Cross-metathesis reactions applications to the synthesis of peptidomimetics as potent falcipain-2 inhibitors 31
Development of isoquinolinone derivatives as immunoproteasome inhibitors. 31
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 30
Drug synergism: studies of combination of RK-52 and curcumin against rhodesain of Trypanosoma brucei rhodesiense 30
Discovery of novel antitrypanosomal agents: design, synthesis of novel benzodiazepine-based peptidomimetics targeting rhodesain, the main cysteine protease of Trypanosoma brucei rhodesiense 30
Progettazione e sintesi di nuovi inibitori del proteasoma quali potenti agenti antitumorali 29
Lead discovery of SARS-CoV-2 main protease inhibitors through covalent docking-based virtual screening 29
Drug repositioning for the treatment of hematologic disease: limits, challenges and future perspectives 29
Development of novel peptidyl nitriles targeting rhodesain and falcipain-2 for the treatment of sleeping sickness and malaria 27
Novel peptidomimetic inhibitors, containing a 1,4-benzodiazepine scaffold, for treatment of neglected tropical diseases 27
Totale 5.175
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.629
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020553 0 0 0 20 4 95 73 49 11 156 114 31
2020/2021755 64 24 120 34 99 85 23 55 81 107 29 34
2021/2022774 11 104 6 48 14 6 65 25 7 53 134 301
2022/20232.305 184 204 104 180 141 231 36 149 971 4 78 23
2023/2024598 69 72 41 145 55 48 6 8 5 62 37 50
2024/2025165 41 23 44 57 0 0 0 0 0 0 0 0
Totale 5.943